Skip to main content
Log in

Effects of cancer and anti-neoplastic treatment on the human testicular function

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Men with testicular neoplasia (TN) and Hodgkin’s disease (HD) are those who more frequently require treatment for fertility because these malignancies affect patients during the reproductive age and because the early diagnosis and the improved anti-neoplastic treatments cure most of these patients. Although some of them can father a child spontaneously, assisted reproductive techniques allow fatherhood to patients with severe spermatogenesis impairment and this possibility has raised concern about the long-term consequence of the testicular damage induced by chemo- and/or radiotherapy. This paper reviews the effects of cancer per se and of anti-neoplastic treatments on gonadal function, sperm aneuploidy rate and sperm DNA integrity. A debate is still open as to whether TN or HD per se may impair spermatogenesis. Many studies have shown that this is the case, albeit others have challenged this view. Chemo- and/or radiotherapy affects negatively gonadal function, rendering almost all patients azoospermics. However, spontaneous pregnancies and a high degree of spermatogenesis recovery occur with time. A large body of literature on sperm chromosome complement suggests an increased rate of structural and numerical chromosome abnormalities in patients with cancer during anti-neoplastic treatment. A minority of them has, however, shown that this effect disappears with time. An interesting and relatively new aspect is the study of sperm DNA integrity in patients with TN and HD particularly following chemo- and/or radiotherapy. The scanty information available seems to suggest that these patients have a permanent or at least a long-lasting DNA fragmentation in their spermatozoa.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dahl O. Testicular carcinoma: a curable malignancy. Acta Radiol. Oncol. 1985, 24: 3–15.

    Article  CAS  PubMed  Google Scholar 

  2. Longo D., Young R., Wesley M., Hubbard S., Duffey P., Jaffe E., De Vita V.J. Twenty years of MOPP therapy for Hodgkin’s disease. J. Clin. Oncol. 1986, 4: 1295–1306.

    CAS  PubMed  Google Scholar 

  3. Perreault S. Gamete toxicology: the impact of new technologies. In: Korach K. (Ed.), Reproduction and developmental toxicology. Marcel Dekker Inc., New York, 1998, pp. 635–641.

    Google Scholar 

  4. Petersen P.M., Skakkebaek N.E., Vistisen K., Rorth M., Giwercman A. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer. J. Clin. Oncol. 1999, 17: 941–947.

    CAS  PubMed  Google Scholar 

  5. Demkow T., Faundez R., Madej G. Sperm, LH FSH, testosterone evaluation in patients with testicular cancer. Preliminary study. Ginekol. Pol. 1998, 69: 405–409.

    CAS  Google Scholar 

  6. Nijman J.M., Schraffordt Koops H., Kremer J., Willemse P.H., Sleijfer D.T., Oldhoff J. Fertility and hormonal function in patients with a nonseminomatous tumor of the testis. Arch. Androl. 1985, 14: 239–246.

    Article  CAS  PubMed  Google Scholar 

  7. Petersen P.M., Skakkebaek N.E., M., Giwercman A. Semen quality and reproductive hormones before and after orchiectomy in men with testicular cancer. J. Urol. 1999, 161: 822–826.

    Article  CAS  PubMed  Google Scholar 

  8. Carroll P.R., Whitmore W.F. Jr., Herr H.W., Morse M.J., Sogani P.C., Bajorunas D., Fair W.R., Chaganti R.S. Endocrine and exocrine profiles of men with testicular tumors before orchiectomy. J. Urol. 1987, 137: 420–423.

    CAS  PubMed  Google Scholar 

  9. Gandini L., Lombardo F., Toselli L., Gilio B., Testani P., Anselmo A.P., Dondero F., Lenzi A. Sperm characteristics before and after therapy in patients with Hodgkin’s disease and testicular neoplasma. J. Endocrinol. Invest. 2000, 23 (Suppl. 8): 28, Abstract OC9.

    Google Scholar 

  10. Hendry W.F., Stedronska J., Jones C.R., Blackmore C.A., Barrett A., Peckham M.J. Semen analysis in testicular cancer and Hodgkin’s disease: pre- and post treatment findings and implications for cryopreservation. Br. J. Urol. 1983, 55: 769–773.

    Article  CAS  PubMed  Google Scholar 

  11. Stephenson W.T., Poirier S.M., Rubin L., Einhorn L.H. Evaluation of reproductive capacity in germ cell tumor patients following treatment with cisplatin, etoposide, and bleomycin. J. Clin. Oncol. 1995, 13: 2278–2280.

    CAS  PubMed  Google Scholar 

  12. Nijman J.M., Schraffordt Koops H., Kremer J., Sleijfer D.T. Gonadal function after surgery and chemotherapy in men with stage II and III nonseminomatous testicular tumors. J. Clin. Oncol. 1987, 5: 651–656.

    CAS  PubMed  Google Scholar 

  13. Drasga R.E., Einhorn L.H., Williams S.D., Patel D.N., Stevens E.E. Fertility after chemotherapy for testicular cancer. J. Clin. Oncol. 1983, 1: 179–183.

    CAS  PubMed  Google Scholar 

  14. Agarwal A., Tolentino M.V. Jr., Sidhu R.S., Ayzman I., Lee J.C., Thomas A.J. Jr., Shekarriz. M. Effects of cryopreservation on semen quality in patients with testicular cancer. Urology 1995, 46: 382–389.

    Article  CAS  PubMed  Google Scholar 

  15. Padron O.F., Sharma R.K., Thomas A.J. Jr., Agarwal A. Effects of cancer on spermatozoa quality after cryopreservation: a 12-year experience. Fertil. Steril. 1997, 67: 326–331.

    Article  CAS  PubMed  Google Scholar 

  16. Vigersky R.A., Chapman R.M., Berenberg A.R. Testicular dysfunction in untreated Hodgkin’s disease. Am. J. Med. 1982, 73: 482–486.

    Article  CAS  PubMed  Google Scholar 

  17. Viviani S., Ragni G., Santoro A., Perotti L., Caccamo E., Negretti E., Valagussa P., Bonadonna G. Testicular dysfunction in Hodgkin’s disease before and after treatment. Eur. J. Cancer 1991, 27: 1389–1392.

    Article  CAS  PubMed  Google Scholar 

  18. Chapman R.M., Sutcliffe S.B., Malpas J.S. Male gonadal dysfuction in Hodgkin’s disease: a prospective study. J. Am. Med. Assoc. 1981, 245: 1323–1328.

    Article  CAS  Google Scholar 

  19. Kulkarni S.S., Satry P.S., Siakia T.K., Parish P.M., Gopal R., Advani S.H. Gonadal function following ABVD therapy for Hodgkin’s disease. Am. J. Clin. Oncol. 1997, 20: 354–357.

    Article  CAS  PubMed  Google Scholar 

  20. Gerres L., Brawswig J.H., Schelgel W., Jurgens H., Schellong G. The effects of etoposide on testicular function in boys treated for Hodgkin’s disease. Cancer 1998, 83: 2217–2222.

    Article  CAS  PubMed  Google Scholar 

  21. Heikens J., Berehndt H., Adriaanse R., Berghout A. Irreversible gonadal damage in male survivors of pedriatic Hodgkin’s disease. Cancer 1996, 78: 2020–2024.

    Article  CAS  PubMed  Google Scholar 

  22. De Braekeleer M., Dao T. Cytogenetic studies in males infertility: a review. Hum. Reprod. 1991, 6: 245–250

    PubMed  Google Scholar 

  23. Alvarez R., Tusell L., Genescà R., Garcia-del-Muro X., Egozcue J. Absence of chromosomal instability in spermatozoa of men affected by testicular cancer. Hum. Reprod. 1999, 14: 247–251.

    Article  CAS  PubMed  Google Scholar 

  24. Templado C., Benet J., Genescà A., Navarro J., Caballin MR., Mirò R., Egozcue J. Human sperm chromosomes. Hum. Reprod. 1988, 3: 133–138.

    CAS  PubMed  Google Scholar 

  25. Jenderny J., Rohborn G. Chromosome analysis of human sperm. I. First results with a modified method. Hum. Genet. 1987, 76: 385–388.

    Article  CAS  PubMed  Google Scholar 

  26. Genescà A., Mirò R., Caballin M.R., Benet J., Germa J.R., Egozcue S. Sperm chromosome studies in individuals treated for testicular cancer. Hum. Reprod. 1990, 5: 286–290.

    PubMed  Google Scholar 

  27. Jenderny J., Jacobi M., Ruger A., Rohrborn G. Chromosome aberration in 450 sperm complements from eight controls and lack of increase after chemotherapy in two patients. Hum. Genet. 1992, 90: 151–154.

    CAS  PubMed  Google Scholar 

  28. Martin R.H., Ernst S., Rademaker A., Barclay L., Ko E., Summers N. Chromosomal abnormlities in sperm from testicular cancer patients before and after chemotherapy. Hum. Genet. 1997, 99: 214–218.

    Article  CAS  PubMed  Google Scholar 

  29. Martin R. Human sperm chromosome complements in chemotherapy patients and infertile men. Chromosoma 1998, 107: 523–527.

    Article  CAS  PubMed  Google Scholar 

  30. Brandriff B.F., Meistrich M.L., Gordon L.A., Carrano A.V., Liang J.C. Chromosomal damage in sperm of patients surviving Hodgkin’s disease following MOPP (nitrogen mustard, vincritine, procarbazine, and prednisone) therapy with and without radiotherapy. Hum. Genet. 1994, 93: 295–299.

    Article  CAS  PubMed  Google Scholar 

  31. Robbins W.A., Marvin M.L., Moore D., Hagermeister F.B., Weier H.U., Cassel M.J., Wilson G., Eskenazi B., Wyrobeck A.J. Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm. Nat. Genet. 1997, 16: 74–78.

    Article  CAS  PubMed  Google Scholar 

  32. Rousseaux S., Sèle B., Cozzi J., Chevret E. Immediate rearrangements of human sperm chromosomes following in vivo irradiation. Hum. Reprod. 1993, 8: 903–907.

    CAS  PubMed  Google Scholar 

  33. Monteil M., Rousseaux S., Chevret E., Pelletier R., Cozzi J., Sele B. Increased aneuploid frequency in spermatozoa from a Hodgkin’s disease patient after chemotherapy and radiotherapy. Cytogenet. Cell Genet. 1997, 76: 134–138.

    Article  CAS  PubMed  Google Scholar 

  34. Gandini L., Lombardo F., Paoli D., Caponecchia L., Familiari G., Verlenga C., Dondero F., Lenzi A. Study of apoptotic DNA fragmentation in human spermatozoa. Hum. Reprod. 2000, 15: 830–839.

    Article  CAS  PubMed  Google Scholar 

  35. Evenson D.P., Klein F.A., Whitmore W.F., Melamed M.R. Flow cytometry evaluation of sperm from patients with testicular carcinoma. J. Urol. 1984, 132: 1220–1225.

    CAS  PubMed  Google Scholar 

  36. Chatterjee R., Haines G.A., Perera D.M.D., Goldstone A., Morris I.D. Testicular and sperm DNA damnage after treatment with fludarabine for chronic lymphocytic leukaemia. Hum. Reprod. 2000, 15: 762–766.

    Article  CAS  PubMed  Google Scholar 

  37. Morris I.D., Hoyes K.P., Taylor M.F., Woolveridge I. Male reproductive toxicology. A review with special consideration to hazards to men. In: Hamamah S., Mieusset R. (Eds.), Male gametes: production and quality. INSERM, Paris, 1996, pp. 135–150.

    Google Scholar 

  38. Haines G., Marples B., Daniel P., Morris I. DNA damage in human and mouse spermatozoa after in vitro irradiation assessed by the comet assay. Adv. Exp. Med. Biol. 1998, 444: 79–93.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aldo E. Calogero.

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Palma, A., Vicari, E., Palermo, I. et al. Effects of cancer and anti-neoplastic treatment on the human testicular function. J Endocrinol Invest 23, 690–696 (2000). https://doi.org/10.1007/BF03343795

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343795

Key-words

Navigation